Beijing Wantai Biological Pharmacy Enterprise Co Ltd has achieved a significant milestone with the approval of its domestically produced nine-valent HPV vaccine, Xinkuning9, marking a new dawn in the HPV vaccine market.

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., a leading healthcare company, is facing financial challenges despite its innovative contributions, prompting a need for strategic reevaluation to secure its future.